Your complete CPD solution
At Visionstryt we specialise in distance learning. Our website offers dozens of CPD points across all competencies with new modules being added every month. Whether you are an Optometrist or an Optical Dispenser, our website offers you a wide range of CPD content just for you.
The Lowdown on Demodex
Demodex is one of the most common, but often overlooked, causes of blepharitis and ocular surface inflammation, being associated with between 29% and 74% of all cases of blepharitis. This article will review demodex, its prevalence, its diagnosis and its treatment.
Enhanced Services in Community Practice
Providing a Minor Eye Conditions Service
The investigation and treatment of a range of common eye conditions has become a significant part of community optometry practice. This article will explain some of the legal framework, practical issues around providing the service, and discuss the treatment of some common conditions.
Meeting the needs of our presbyopic patients
This article will provide an introduction to presbyopia and discuss management options, including spectacle, contact lens and surgical correction.
Lenses and Harmful Light Protection
This article will provide an overview of harmful light, including sources of exposure and the effects on the eye. In addition, the different types of protective lenses that are available, and how these are manufactured will be discussed.
Is small incision lenticular extraction really something to SMILE about?
This article will cover the history of modern refractive surgery and describe the SMILE procedure.
Getting on the right tract with uveitis
This course will review 4 patient cases with presenting with different types of anterior uveitis. For each case, symptoms, diagnosis, referral and management will be discussed.
How to Interpret OCT Images: Common Case Histories
This course will discuss the key features of common ocular pathologies to help optometrists make an accurate diagnosis using OCT imaging.
New Treatments for Dry AMD
This lecture will provide some background into age-related macular degeneration (AMD), discuss how the AMD-risk associated mutations affect our immune system and talk about new therapies currently being developed.